GLP-1 medicines cause malnutrition in 22% of patients. Multivitamins are often inadequate. Patients need dietitian support ...

A pile of pills and a measuring tape illustrate rising demand for weight-loss medications amid increasing reports of misuse ...

A new study finds a possible association between GLP-1 drugs like semaglutide and chronic cough, though the authors are ...

Imagine if losing weight were as simple as swallowing a daily pill-no needles, no injections and no anxiety. If you're among ...

There are still good reasons to invest in the stock at current levels.

With thousands of press releases published each month, it can be difficult to keep up with everything on PR Newswire. To help ...

They’re definitely easier and more affordable than injectables, but do they work as well? Here’s what you need to know.

Details from two large trials of Novo Nordisk’s GLP-1 drug semaglutide showed it provided no cognitive benefit for people ...

There have been some interesting failures recently in Alzheimer’s trials. Two are notable because they’re aimed outside the ...

A large new trial falls short of experts’ expectations for combating the neurodegenerative disease. But there could still be ...

Novo Nordisk in 2020 launched pivotal trials of its GLP-1 drug semaglutide in Alzheimer's patients based on studies in humans ...